This study is dedicated to research molecular marker’s expression in the differentiated thyroid tumors for prognosis of subsequent clinical course. In this study thyroid tumors were analyzed for NIS, thyroglobulin, galectin-3, p53 expression as well as for proliferation activity (based on Ki-67 expression) depending on the presence of metastases and invasion level. It was identified the prognostic value of each marker of biological properties. The immunophenotypes of thyroid cancers with high risk of tumor dissemination were established. The differential diagnostic marker of follicular tumors was proposed as well. These immunomorphology tumor profile based findings allow to predict the clinical course of thyroid cancer that make possible to...
Because most differentiated thyroid carcinomas have an excellent prognosis, some authors have claime...
The treatment of thyroid cancer that is unable to concentrate the radioiodine is problematic. The id...
Thyroid cancer is the most common endocrine malignancy. Recent developments in molecular biological ...
In Papillary Thyroid Cancer (PTC) in recent years an immunohistochemical markers were detected. Seve...
Epithelial thyroid cancers are represented by the differentiated papillary and follicular thyroid ca...
AbstractEpithelial thyroid cancers are represented by the differentiated papillary and follicular th...
Thyroid cancer remains the most common malignancy of the endocrine system worldwide. The indicators ...
In this volume it was described the role of the biological and molecular markers for the diagnosis, ...
The large use of simple and effective diagnostic tools has significantly contributed to the increase...
Age is the most accepted prognostic factor in differentiated thyroid cancer. Other parameters, such ...
Background and Objective. Distinction between benign and malignant thyroid tumors is essential for p...
Age is the most accepted prognostic factor in differentiated thyroid cancer. Other parameters, such ...
Aims: To investigate the usefulness of immunohistochemical expression and immunolocalization of a pa...
PURPOSE: Thyroid nodules are of common occurrence in the general population. About a fourth of these...
Thymic epithelial tumors are characterized by a remarkable variability with regard to morphology, bi...
Because most differentiated thyroid carcinomas have an excellent prognosis, some authors have claime...
The treatment of thyroid cancer that is unable to concentrate the radioiodine is problematic. The id...
Thyroid cancer is the most common endocrine malignancy. Recent developments in molecular biological ...
In Papillary Thyroid Cancer (PTC) in recent years an immunohistochemical markers were detected. Seve...
Epithelial thyroid cancers are represented by the differentiated papillary and follicular thyroid ca...
AbstractEpithelial thyroid cancers are represented by the differentiated papillary and follicular th...
Thyroid cancer remains the most common malignancy of the endocrine system worldwide. The indicators ...
In this volume it was described the role of the biological and molecular markers for the diagnosis, ...
The large use of simple and effective diagnostic tools has significantly contributed to the increase...
Age is the most accepted prognostic factor in differentiated thyroid cancer. Other parameters, such ...
Background and Objective. Distinction between benign and malignant thyroid tumors is essential for p...
Age is the most accepted prognostic factor in differentiated thyroid cancer. Other parameters, such ...
Aims: To investigate the usefulness of immunohistochemical expression and immunolocalization of a pa...
PURPOSE: Thyroid nodules are of common occurrence in the general population. About a fourth of these...
Thymic epithelial tumors are characterized by a remarkable variability with regard to morphology, bi...
Because most differentiated thyroid carcinomas have an excellent prognosis, some authors have claime...
The treatment of thyroid cancer that is unable to concentrate the radioiodine is problematic. The id...
Thyroid cancer is the most common endocrine malignancy. Recent developments in molecular biological ...